Capricor, Inc. is a cutting edge company developing novel adult stem cell therapies for heart disease. Capricor’s lead drug product candidate, allogeneic Cardiosphere Derived Cells (CDCs) known as CAP-1002, is being in - Adult stem cell - Document - PDFSEARCH.IO

First Page	Meta Content
	Capricor, Inc. is a cutting edge company developing novel adult stem cell therapies for heart disease. Capricor’s lead drug product candidate, allogeneic Cardiosphere Derived Cells (CDCs) known as CAP-1002, is being in Add to Reading List Document Date: 2015-09-18 09:40:56 Open Document File Size: 49,63 KB Share Result on Facebook

Capricor, Inc. is a cutting edge company developing novel adult stem cell therapies for heart disease. Capricor’s lead drug product candidate, allogeneic Cardiosphere Derived Cells (CDCs) known as CAP-1002, is being inAdd to Reading List